Recently, a genome-wide CRISPR–Cas9 screen uncovered enrichment of sgRNAs targeting members of the STAGA HAT complex in the presence of vemurafenib25, consistent with a critical role for histone acetylation in melanoma drug resistance. This evidence concerns the gene TMPRSS11D and melanoma.